Development of SARS-CoV-2 as a viral vector: A novel intranasal bivalent vaccine for SARS-CoV-2 and RSV
- Journal:
- Science Advances
- Published:
- Affiliations:
- 6
- Authors:
- 17
| Institutions | Authors | Share |
|---|---|---|
| The Ohio State University (OSU), United States of America (USA) | 0.80 | |
| OSU Department of Pediatrics (Nationwide Children's Hospital), United States of America (USA) | 0.20 |